Trials / Conditions / Adverse Drug Reaction

Adverse Drug Reaction

24 registered clinical trials studyying Adverse Drug Reaction — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Active Pharmacovigilance Study of the Medicine Rinvoq™ (Upadacitinib) NCT06498167	Universidade do Porto	—
Active Not Recruiting	Personalised Therapeutics @LUMC NCT05508763	Leiden University Medical Center	—
Recruiting	The Texas Interprofessional Pharmacogenomics (IPGx) NCT06219720	Texas A&M University	—
Unknown	Evaluating ActionADE in Reducing Adverse Drug Reactions NCT04568668	University of British Columbia	N/A
Completed	Pharmacists' Knowledge and Attitudes About ADRs Reporting and Pharmacovigilance Practice in Egyptian Hospitals NCT05224804	Fayoum University	—
Completed	Reducing Costs by Deprescribing Medications NCT04553107	The University of Texas Health Science Center, Houston	N/A
Recruiting	Pharmacogenetic Testing of Patients With Unwanted Adverse Drug Reactions or Therapy Failure NCT04154553	University Hospital, Basel, Switzerland	—
Suspended	Drug Interactions in Outpatients. NCT03943524	University of Buenos Aires	N/A
Completed	PREemptive Pharmacogenomic Testing for Preventing Adverse Drug REactions NCT03093818	J.J.Swen	N/A
Unknown	Deprescribing of Symptomatic Medications in Rehabilitative or Subacute Care Patients NCT03354845	Bright Vision Hospital	N/A
Completed	Adverse Drug Reactions With Fatal Outcome NCT02838212	Germans Trias i Pujol Hospital	—
Suspended	Post-marketing Safety Surveillance of Breviscapine Powder-Injection : a Registry Study NCT02559960	Zhong Wang	—
Completed	A Prospective Trial to Assess Cost and Clinical Outcomes of a Clinical Pharmacogenomic Program NCT02297126	Indiana University	N/A
Completed	Post-Marketing Surveillance of the Tanreqing Injection: a Real World Study NCT02094638	Suodi ZHAI	—
Unknown	Antidepressant Monotherapy on Depressive and Anxiety Symptom in Chinese Patients NCT02012504	Shanghai Zhongshan Hospital	—
Completed	The Drug Induced Renal Injury Consortium NCT02159209	Ravindra Mehta	—
Completed	Serious Adverse Drug Reaction and Their Preventability NCT02888834	CHU de Reims	—
Unknown	the Pharmacy Intervention Team Hospital-based (PITH) for People Study: Effect on Clinical and Economic Outcome NCT01906710	Clementine CM Stuijt PharmD, MSc	N/A
Completed	Educational Intervention to Reduce Drug-related Hospitalizations in Elderly Primary Health Care Patients NCT01732302	Karolinska Institutet	N/A
Completed	Post-Marketing Surveillance of the Cinepazide Maleate Injection: a Real World Study NCT01946919	Peking University Third Hospital	—
Completed	Sustained Virological Suppression and Improvement of Adverse Events of Switching to Raltegravir Study NCT01679964	Lin, Hsi-Hsun, M.D.	Phase 4
Completed	Post-marketing Safety Surveillance of the Injection of DanShenDuoFenSuanYan A Real World Study NCT01872520	Peking University Third Hospital	—
Completed	Educational Intervention in Pharmacovigilance for Hospital Health Professionals NCT02134587	Universidade Estadual Paulista Júlio de Mesquita Filho	N/A
Completed	Prevention of Adverse Drug Events (ADEs) in Hospitalised Older Patients NCT01467050	University College Cork	Phase 4